PaySign (PAYS) AI Stock Analysis

• Market Cap: $277.70M
• Dividend Yield: N/A
• Average Volume (3M): 466.97K
• Price to Earnings (P/E): 43.1
• Beta (1Y): 1.94
• Revenue Growth: 27.84%
• EPS Growth: -13.78%
• Country: US
• Employees: 173
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Infrastructure
• EPS (TTM): 0.02
• Shares Outstanding: 54,451,890
• 10 Day Avg. Volume: 305,965
• 30 Day Avg. Volume: 466,966
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.10
• Enterprise Value/Revenue: 4.46
• Enterprise Value/Gross Profit: 7.83
• Enterprise Value/Ebitda: 23.73
• 1Y Price Target: $10.00
• Price Target Upside: 95.69% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 70 Outperform
• Price Target: $6.00 ▲(17.42% Upside)

PaySign's overall stock score is driven by strong financial performance and positive earnings call highlights, including record revenue growth and increased guidance. However, the high P/E ratio and technical indicators suggest caution. The company's challenges in the plasma compensation business and industry headwinds also weigh on the score.

Positive Factors

Revenue Growth

Strong revenue growth indicates expanding market reach and effective business strategies, which are crucial for long-term success and competitiveness.

Product Expansion

The introduction of new software solutions enhances product offerings, potentially increasing customer engagement and opening new revenue streams.

Cash Generation

Strong cash generation supports investment in growth opportunities and enhances financial stability, crucial for sustaining operations and strategic initiatives.

Negative Factors

Plasma Business Challenges

Declining revenue in the plasma business suggests challenges in a key segment, which could impact overall growth and profitability if not addressed.

Profit Margin Pressure

Decreasing profit margins indicate potential cost pressures or pricing challenges, which could affect long-term profitability and competitive positioning.

Industry Headwinds

Industry headwinds in the plasma sector could limit growth and profitability, necessitating strategic adjustments to mitigate these challenges.

PaySign Business Overview & Revenue Model

Company Description

PaySign, Inc. (PAYS) is a financial technology company specializing in digital payment solutions, primarily focusing on prepaid card programs and payment processing services. The company serves various sectors, including healthcare, retail, and e-commerce, providing innovative payment solutions designed to enhance consumer engagement and operational efficiency. PaySign's core products include prepaid debit cards, payment processing platforms, and mobile payment solutions, tailored to meet the needs of businesses and individuals alike.

How the Company Makes Money

PaySign generates revenue through multiple streams, primarily from transaction fees associated with the use of its prepaid card programs and payment processing services. The company earns a percentage of each transaction processed, which varies based on the type of service provided. Additionally, PaySign charges fees for card issuance, monthly maintenance, and other ancillary services related to its prepaid card offerings. Strategic partnerships with healthcare providers, businesses, and financial institutions significantly contribute to its earnings by expanding its customer base and enhancing service offerings. Furthermore, the company may also generate revenue from interest earned on stored funds and other financial services related to its payment solutions.

PaySign Financial Statement Overview

Summary

PaySign demonstrates strong revenue growth and improving operational efficiency. Despite some pressure on net profitability, the company maintains a healthy balance sheet with low leverage and strong cash flows, positioning it well for future growth and stability. However, the relatively low net profit margin and stockholders' equity warrant careful monitoring to ensure long-term financial health.

Income Statement

PaySign showed a strong revenue growth of 23.5% over the past year, indicating a positive trajectory. The gross profit margin stands at 55.1%, which is solid for the industry. However, the net profit margin has decreased to 6.5% from 13.7% last year, indicating some profitability pressure. The EBIT margin has improved to 1.7%, recovering from negative figures in prior years, showing signs of operational improvement.

Balance Sheet

The debt-to-equity ratio is low at 0.1, indicating minimal leverage, which is beneficial for financial stability. Return on equity is 12.5%, showing reasonable profitability relative to shareholder equity. The equity ratio is 17%, which is moderate and suggests a balanced capital structure. However, the stockholders' equity is relatively low compared to total liabilities, indicating potential risk if liabilities increase.

Cash Flow

Operating cash flow increased to $22.9 million, showcasing robust cash generation capabilities. Free cash flow also showed growth, which is a positive sign for future investments and debt servicing. The operating cash flow to net income ratio is high at 6.0, indicating strong cash conversion efficiency. The free cash flow to net income ratio is 5.9, reinforcing the company's strong cash position relative to earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	68.54M	58.38M	47.27M	38.03M	29.46M	24.12M
Gross Profit	39.00M	32.20M	24.14M	20.95M	14.71M	9.30M
EBITDA	12.88M	7.02M	3.86M	3.25M	-213.22K	-5.79M
Net Income	6.78M	3.82M	6.46M	1.03M	-2.72M	-9.14M
Balance Sheet
Total Assets	193.90M	179.03M	146.60M	108.24M	84.05M	67.83M
Cash, Cash Equivalents and Short-Term Investments	113.91M	10.77M	16.99M	9.71M	7.39M	7.83M
Total Debt	2.72M	2.93M	3.31M	3.67M	4.01M	4.33M
Total Liabilities	151.69M	148.59M	122.11M	91.95M	71.06M	54.60M
Stockholders Equity	42.21M	30.44M	24.49M	16.29M	12.99M	13.24M
Cash Flow
Free Cash Flow	-14.97M	13.46M	20.57M	21.23M	12.55M	10.43M
Operating Cash Flow	-8.24M	22.95M	27.62M	25.32M	15.23M	13.78M
Investing Cash Flow	-11.10M	-9.49M	-7.05M	-4.09M	-2.68M	-3.34M
Financing Cash Flow	-274.50K	-466.25K	-1.12M	0.00	192.14K	-72.86K

PaySign Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 5.11
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PAYS, the sentiment is Negative. The current price of 5.11 is below the 20-day moving average (MA) of 5.47, below the 50-day MA of 5.57, and above the 200-day MA of 4.52, indicating a neutral trend. The MACD of -0.15 indicates Positive momentum. The RSI at 39.01 is Neutral, neither overbought nor oversold. The STOCH value of 9.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PAYS.

PaySign Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IMXI	75 Outperform	$444.07M	9.15	36.15%	―	-4.19%	-3.52%
PAYO	73 Outperform	$1.97B	27.78	9.79%	―	10.58%	-45.52%
PAYS	70 Outperform	$277.70M	43.11	19.65%	―	27.84%	-13.78%
AVPT	62 Neutral	$2.93B	―	-2.60%	―	24.41%	40.20%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
RPAY	48 Neutral	$358.64M	―	-15.33%	―	1.45%	-28.78%
BKKT	41 Neutral	$498.74M	-4.92	-70.04%	―	111.83%	73.52%

PaySign Corporate Events

PaySign Settles Stockholder Derivative Actions

On November 25, 2024, Paysign, a company involved in financial services, entered into a Stipulation and Agreement of Settlement to resolve stockholder derivative actions pending in the United States District Court for the District of Nevada. These actions alleged violations of the Exchange Act, breaches of fiduciary duty, unjust enrichment, and waste. The settlement, which is not an admission of fault, requires Paysign to adopt corporate governance reforms and will result in the dismissal of the actions with prejudice, pending court approval. The settlement is seen as beneficial for the company and its shareholders, avoiding the costs and risks of litigation.

The most recent analyst rating on (PAYS) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on PaySign stock, see the PAYS Stock Forecast page.

Paysign Inc. Reports Record Revenue and Strategic Growth

The recent earnings call for Paysign, Inc. highlighted a generally positive sentiment, driven by strong growth in the company’s patient affordability business and successful expansion strategies. Despite facing challenges in the plasma segment, such as declining revenue and the closure of underperforming centers, the company’s record revenue and strategic initiatives were key highlights that overshadowed these issues.

Paysign, Inc. Reports Strong Q2 2025 Growth

Paysign, Inc. is a financial services company specializing in prepaid card programs, pharma patient affordability solutions, and integrated payment processing, primarily serving the healthcare industry. In its second quarter of 2025, Paysign reported a significant increase in total revenues, reaching $19.08 million, a 33.1% rise from the previous year. The company also saw a substantial growth in net income, which nearly doubled to $1.39 million, and adjusted EBITDA more than doubled to $4.51 million. Key performance highlights include the addition of 123 net plasma centers and seven new pharma patient affordability programs, contributing to a 189.9% increase in pharma revenue. Despite a decrease in plasma revenue due to industry-wide oversupply, the company’s overall gross profit increased by 55%, driven by the strong performance in the pharma sector. Looking forward, Paysign plans to expand its plasma offerings and scale its operations to meet the growing demand for its pharma solutions, with expectations of continued revenue growth and strategic expansion in the healthcare market.